T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.

about

Gene therapy for paediatric leukaemia.The next wave of recombinant and synthetic anticancer vaccines.Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer.Specificity in cancer immunotherapy.Prostate cancer health disparities: An immuno-biological perspective.

P2860

Q34451905-78BECE84-A249-497F-99CD-E8CC838CB7D3 Q36470749-06B73541-372E-4981-A420-BD72983BC933 Q36709561-2CEC0394-2D78-436C-A6B1-C587F3124E88 Q37236636-C8AB2BA0-3275-44CF-AC52-D30B3EB57432 Q46537204-E66BDDDD-6F2F-4603-B824-FA2C9D251430

P2860

T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.

Item

http://www.wikidata.org/entity/Q40712555

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

1993年论文

@zh

1993年论文

@zh-cn

name

T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.

@en

type

Item

label

T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.

@en

prefLabel

T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.

@en

P1476

T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.

@en

P2093

Cheever MA

http://www.w3.org/2001/XMLSchema#string

Chen W

http://www.w3.org/2001/XMLSchema#string

Disis ML

http://www.w3.org/2001/XMLSchema#string

Peace DJ

http://www.w3.org/2001/XMLSchema#string

Takahashi M

http://www.w3.org/2001/XMLSchema#string

P2860

A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene

The GTPase superfamily: a conserved switch for diverse cell functions

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus.

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells

Ras oncogene mutation in multiple myeloma

Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response.

T-cell immunity to the joining region of p210BCR-ABL protein

Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.

P304

101-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.1993.TB44000.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

690

http://www.w3.org/2001/XMLSchema#string

P577

1993-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15094910

http://www.w3.org/2001/XMLSchema#string

P698

8103658

http://www.w3.org/2001/XMLSchema#string

T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.

about

P2860

P2860

T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698